-
Primus Pharmaceuticals, Inc
Distance: 101.7 Mi4725 N Scottsdale Rd Ste 200
85251-7628 Scottsdale -
PharmaLabs, LLC
Distance: 104.9 Mi8989 N Gainey Center Dr Unit 237
85258-2115 Scottsdale
Description
AmpliMed® Corporation, a clinical-stage pharmaceutical company founded by world-renowned oncologists, has a lead compound, Amplimexon®, in Phase II clinical trials, with early evidence of efficacy and low levels of toxicity. The Company also has two other promising drug candidates, benzimate, which entered Phase I clinical study during 2006, and Amplizone™, which is scheduled to begin Phase I studies in 2007. The Company is focused on the development of small-molecule oncology drugs with novel mechanisms of action.